New Delhi, Sep 19 (PTI) Natco Pharma on Monday said it has received a court order allowing it to launch insecticide Chlorantraniliprole (CTPR) and its formulations.

The company has received an order from the Delhi High Court to launch the insecticide through a non-infringing process, the Hyderabad based company said in a regulatory filing.

Also Read | How to Remove Leaked MMS, Videos and Photos From Social Media or Website? Know Steps Here.

US-based FMC Corporation had filed a patent infringement case against Natco Pharma in Delhi High Court.

The company said it is the first in the country to have received registration approval from Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacturing of CTPR.

Also Read | UPSC CAPF Result 2022 Declared at upsc.gov.in; Know Steps To Check Score.

The product is used across a wide range of crops for pest management.

As per the company, the current market size of CTPR containing products in India is estimated to be around Rs 2,000 crore.

The company plans to launch its products very shortly, Natco Pharma said.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)